Diagnostic and treatment aspects of Lyme Neuroborreliosis

T Akhvlediani, N Kvirkvelia, T Tsertsvadze, R Shakarishvili


Lyme borreliosis is the most common tick-borne disease in Europe and North America. Nervous system involvement– neuroborreliosis  - is the most common manifestation  of the disseminated  Lyme disease. In Georgia,  there is no information  about the prevalence  of borreliosis  even though it is considered  as an endemic  disease  and there is enough  evidence  to suspect  that it is underdiagnosed. This article  reviews  certain  challenging  aspects  of clinical manifestation,  diagnosis and treatment of Lyme neuroborreliosis. 


Lyme borreliosis, neuroborreliosis

Full Text:



Hanningsson AJ, Christiansson M, Tjernberg I, et al. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays. Eur J Clin Microbiol Infect Dis. 2014; 33:797-803

Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum 1977; 20: 7-17.

Maletskaia OV, Beliaeva AI, Taran TV, Agapitov DS, Klichenko AN. [Epidemiologic situation on dangerous infectious diseases on the territory of Republic of Abkhazia]. Zh Mikrobiol Epidemiol Immunobiol. 2013;5: 43-7. [Article in Russian]

Kaya AD, Parlak AH, Ozturk CE, Behcet M. Seroprevalence of Borrelia burgdorferi infection among forestry workers and farmers in Duzce, north-westernTurkey. New Microbiol. 2008;31:203-9.

Güner ES, Hashimoto N, Takada N, Kaneda K, Imai Y, Masuzawa T. First isolation and characterization of Borrelia burgdorferi sensu lato strains from Ixodes ricinus ticks in Turkey. J Med Microbiol. 2003; 52: 807-13.

Malkhazova SM, Mironova VA, Kotova TV, Shartova NV, Orlov DS. Natural-focal diseases: mapping experience in Russia. Int J Health Geogr. 2014; 13:21

Baranova E, Solov Ev P, Panfertsev E, et al. Rational design of antigens to improve the serodiagnosis of tick-borne borreliosis in central regions of Russia. Adv Exp Med Biol. 2014;807:9-21


Rupprecht TA, Fingerle V. Neuroborreliosis: pathogenesis, symptoms, diagnosis and treatment. Future Neurol. 2011; 6: 273-289.

Hildenbrand P, Craven DE, Jones R, Nemeskal P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol. 2009; 30:1079-87.

Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA: Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur. J. Clin. Microbiol. Infect. Dis. 1999; 18:697–703.

P achner AR. Lyme disease. Trends Neurosci 1989; 12:177-81

Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lymeborreliosis. Lancet Infect. Dis. 2003; 3:489–500.

Steere AC: Lyme disease. N. Engl. J. Med. 2001; 345: 115–125.

Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect. Dis. 2003; 3:

Satz N: Klinik der Lyme-Borreliose. Verlag Hans Huber, Bern, 2. Auflage, 2002.

Halperin JJ, Volkman DJ, Luft BJ, Dattwyler RJ. Carpal tunnel syndrome in Lyme borreliosis. Muscle Nerve. 2989; 12: 397-400

Auwaerter PG. Point: antibiotic therapy is not the answer

for patients with persisting symptoms attributable to

Lyme disease. Clin Infect. Dis. 2007; 45: 143-148.

Pfister HW, Rupprecht TA: Clinical aspects of neuroborreliosis andpost-Lyme disease syndrome in adult patients. Int. J. Med. Microbiol. 2006; 296(Suppl.1): 11–16.

Nau R, Christen H, Eiffert H. Lyme Disease – Current

State of Knowledge. Dtsch Arztebl Int 2009; 106: 72–82

Wilske B, Volker Fingerle V,S chulte-Spechtel U. Microbiological and serological diagnosis of Lymeborreliosis. Immunol Med Microbiol. 2007; 49: 13–21

Narayan K, Dail D, LiL et al: The nervous system as

ectopic germinal center: CXCL13 and IgG in Lyme neuroborreliosis. Ann. Neurol. 2005;57: 813-823.

Ramesh G, Borda JT, Gill A et al: Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J. neuroinflammation. 2009; 6: 23.

Rupprecht TA, Plate A, Adam M et al.: The chemokine

CXCL13 is a key regulator of B cell recruitment to the

cerebrospinal fluid in acute Lyme neuroborreliosis. J.

Neuroinflammation. 2009; 6: 42.

Ljostad U, Mygland A:CSFB-lymphocyte chemoattractant (CXCL13)in the early diagnosis of acute Lyme neuroborreliosis. J. Neurol. 2008; 255:732–737.

Rupprecht TA, Kirschning CJ, Popp B et al: Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2. Infect. Immun. 2007; 75:4351-4356

Mygland A, Ljøstad U, Fingerle V, Rupprecht T,

Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. European Journal of Neurology 2010,17: 8–16

Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical

assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis and babesiosis: Clinical practice guidelines by the infectious diseases society of America. IDSA Guidelines 2006; 43: 1089–134.

Pfister HW, Preac-Mursic V, Wilske B, Einhaupl KM:

Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch. Neurol. 1989; 46: 1190-1194.


  • There are currently no refbacks.


Become a REVIEWER 


ISSN: 2346-8491 (online)